Qbrexza (glycopyrronium) is a prescription medication used to treat underarm sweating, also known as axillary hyperhidrosis [1]. It is an anticholinergic medication that works by blocking the action of acetylcholine, a neurotransmitter that stimulates sweat glands [2].
How does Qbrexza work to stop sweating?
Qbrexza contains the active ingredient glycopyrronium, which is an anticholinergic. It works by blocking the effects of acetylcholine on the sweat glands in the underarms. Acetylcholine is a chemical messenger that tells the sweat glands to produce sweat. By blocking acetylcholine, glycopyrronium reduces the amount of sweat produced [2].
What are the side effects of using Qbrexza?
Common side effects of Qbrexza include dry mouth, blurred vision, pupil dilation, and difficulty urinating [1][2]. Some individuals may also experience eye irritation or pain [1]. It is important to use Qbrexza as directed and to discuss any concerns with a healthcare provider.
How is Qbrexza administered?
Qbrexza is applied topically to the underarm area as a single-use cloth wipe [1].
When does Qbrexza's patent expire?
Information regarding the specific patent expiration dates for Qbrexza is not readily available in the provided context. Patent information for pharmaceuticals is often complex and can be found through specialized databases [3].
Who manufactures Qbrexza?
Dermira, Inc. is the company that developed and markets Qbrexza [1].
How does Qbrexza compare to other hyperhidrosis treatments?
Qbrexza offers a topical application for axillary hyperhidrosis, distinguishing it from systemic medications or procedures. Other treatment options for excessive underarm sweating include topical antiperspirants, oral medications, iontophoresis, and surgical interventions [4]. The choice of treatment often depends on the severity of sweating and individual patient factors.
What clinical data supports Qbrexza's effectiveness?
Clinical studies have demonstrated that Qbrexza significantly reduces sweating in individuals with axillary hyperhidrosis. In clinical trials, a substantial percentage of participants experienced a reduction in sweat production after using Qbrexza [1].
Are there any contraindications for Qbrexza use?
Qbrexza should not be used by individuals with certain medical conditions, including glaucoma, myasthenia gravis, or Sjogren's syndrome, as it can worsen these conditions. It is also contraindicated in patients with known hypersensitivity to glycopyrronium or any of its components [2].
Sources:
[1] https://www.qbrexza.com/
[2] https://www.rxlist.com/consumer/medications/qbrexza/article.htm
[3] https://drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/hyperhidrosis/diagnosis-treatment/drc-20367183